Biotech Values

[ghmm]

MNTA:

Thanks for providing the updated analysis.

For the most part I had been happy with Wheeler but I think he really dropped the ball by waiting out the FDA (on M-Enox) to partner M118. It reminds me a bit of what Givens (ENCY) did with the just a little more data and the FDA will be happy. I think its too hard to run a company trying to time it with FDA decisions. I would have been happy with a partnership where they pay development costs and we may not get up-front money and say a descent royalty instead. Granted I have no idea if he could have gotten such a deal so perhaps he is doing the best he could. I get disappointed with management letting things sit even if we have to give up some upside to keep it going.